The Discovery of Novel PGK1 Activators as Apoptotic Inhibiting and Neuroprotective Agents
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.877706
Abstract: Stroke is the second leading cause of death worldwide and the leading cause of long-term disability that seriously endangers health and quality of human life. Tissue-type fibrinogen activator is currently the only drug approved by… read more here.
Keywords: activators apoptotic; discovery novel; novel pgk1; pgk1 ... See more keywords